13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 65 holding rows worth $542,288,634.
- Accession
- 0001420506-25-002146
- Filer
- CIK 1816307
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 65 entries on the cover page, a total value of $542,288,634 stated on the cover page (in dollars after the unit check, H1), rows summing to $542,288,634 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSilverArc Capital, LLC 028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MERUS N V | N5749R100 | COM | 741,972 | $39,027,727 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 713,811 | $38,088,955 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 358,297 | $33,887,730 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 2,022,482 | $27,708,003 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 400,772 | $25,324,783 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 249,060 | $25,065,398 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,832,171 | $20,712,693 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 162,969 | $20,483,574 | dollars as filed | |
| MERUS N V | N5749R900 | CALL DE | 382,500 | $20,119,500 | dollars as filed | call |
| 89BIO INC | 282559103 | COM | 2,037,087 | $20,004,194 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,800,829 | $18,278,414 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 235,583 | $17,974,983 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 204,591 | $17,140,634 | dollars as filed | |
| SPDR SERIES TRUST | 78464A900 | ST STR SP BIOT | 200,000 | $16,586,000 | dollars as filed | call |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 86,552 | $14,938,875 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 541,034 | $14,066,884 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 448,495 | $12,122,820 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 341,010 | $12,078,574 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 410,000 | $11,644,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 287,796 | $9,356,248 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 344,338 | $8,346,753 | dollars as filed | |
| NUVALENT INC | 670703907 | Equity Call | 100,200 | $7,645,260 | dollars as filed | call |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 613,393 | $6,514,234 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 5,146,782 | $6,330,542 | dollars as filed | |
| METSERA INC | 59267L107 | COM | 207,581 | $5,905,679 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 2,761,684 | $5,468,134 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 3,033,879 | $5,400,305 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 2,779,795 | $5,392,802 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 917,898 | $5,213,661 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 103,943 | $5,063,064 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 198,441 | $4,038,274 | dollars as filed | |
| AARDVARK THERAPEUTICS INC | 002942100 | COM | 286,807 | $3,877,631 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 82,023 | $3,871,486 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 402,964 | $3,773,758 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 175,636 | $3,642,691 | dollars as filed | |
| COGENT COMM HOLDINGS INC | 19239V902 | COM NEW | 500,000 | $3,590,000 | dollars as filed | call |
| CERUS CORP | 157085101 | COM | 2,488,291 | $3,508,490 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,569,591 | $3,263,381 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,249,781 | $3,249,431 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 186,015 | $3,227,360 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 253,234 | $2,962,838 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 539,587 | $2,951,541 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 202,565 | $2,823,756 | dollars as filed | |
| HIMS & HERS HEALTH INC | 433000956 | PUT | 50,000 | $2,492,500 | dollars as filed | put |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 75,959 | $2,101,786 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 165,389 | $1,854,011 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 95,806 | $1,784,866 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 109,257 | $1,747,019 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 115,282 | $1,559,765 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 401,540 | $1,497,744 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B959 | COM NEW | 144,700 | $1,436,871 | dollars as filed | put |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 103,026 | $1,401,154 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y908 | CALL | 25,000 | $1,334,000 | dollars as filed | call |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 3,128,421 | $926,013 | dollars as filed | |
| RADIOPHARM THERANOSTICS LTD | 75041J101 | SPONSORED ADS | 187,406 | $869,564 | dollars as filed | |
| MODULAR MED INC | 60785L207 | COM NEW | 710,363 | $529,220 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F905 | COM | 50,000 | $468,000 | dollars as filed | call |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 10,000 | $420,500 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 202,590 | $328,196 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 1,070,367 | $302,058 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 37,539 | $286,047 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 10,000 | $200,600 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 5,000 | $65,700 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 346 | $8,941 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 104,828 | $3,019 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-002146 | this filing | 2025-08-14 | acceptance time not in the bulk data set |